AL-S Pharma
Schlieren
About AL-S Pharma
AL-S Pharma AG develops AP-101, a human monoclonal antibody targeting misfolded SOD1 for the treatment of ALS.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Dec 2016)
Industries & Categories
Health Care, Medical
Canonical: https://fsome.com/organization/al-s-pharma-2248474 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.